A detailed history of Retirement Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Retirement Group, LLC holds 354 shares of GILD stock, worth $32,713. This represents 0.01% of its overall portfolio holdings.

Number of Shares
354
Previous 223 58.74%
Holding current value
$32,713
Previous $18,000 38.89%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$71.58 - $87.29 $9,376 - $11,434
131 Added 58.74%
354 $25,000
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $2,198 - $2,492
30 Added 15.54%
223 $18,000
Q3 2023

Nov 06, 2023

SELL
$73.94 - $80.67 $2,070 - $2,258
-28 Reduced 12.67%
193 $14,000
Q2 2023

Aug 15, 2023

SELL
$76.01 - $86.7 $9,501 - $10,837
-125 Reduced 36.13%
221 $17,000
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $77 - $88
1 Added 0.29%
346 $29,000
Q4 2022

Feb 15, 2023

BUY
$62.32 - $89.47 $810 - $1,163
13 Added 3.92%
345 $30,000
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $893 - $1,020
15 Added 4.73%
332 $20,000
Q2 2022

Aug 04, 2022

SELL
$57.72 - $65.01 $692 - $780
-12 Reduced 3.65%
317 $20,000
Q1 2022

May 06, 2022

BUY
$57.92 - $72.58 $7,935 - $9,943
137 Added 71.35%
329 $20,000
Q3 2021

Nov 16, 2021

SELL
$67.69 - $73.03 $10,153 - $10,954
-150 Reduced 43.86%
192 $13,000
Q1 2021

May 04, 2021

BUY
$60.0 - $68.46 $60 - $68
1 Added 0.29%
342 $22,000
Q4 2020

Feb 22, 2021

BUY
$56.65 - $64.55 $113 - $129
2 Added 0.59%
341 $19,000
Q3 2020

Nov 16, 2021

SELL
$62.1 - $78.08 $136,930 - $172,166
-2,205 Reduced 86.67%
339 $21,000
Q3 2020

Sep 08, 2021

BUY
$62.1 - $78.08 $147,922 - $185,986
2,382 Added 1470.37%
2,544 $122,000
Q2 2020

Sep 08, 2021

BUY
$72.34 - $84.0 $9,114 - $10,584
126 Added 350.0%
162 $12,000
Q4 2019

Aug 30, 2021

BUY
$61.62 - $67.78 $2,218 - $2,440
36 New
36 $2,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Retirement Group, LLC Portfolio

Follow Retirement Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Group, LLC with notifications on news.